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Abstract 39 
Aims: Adhesion of a microorganism to a cell surface is often considered to be the first 40 
step in pathogenesis. Inhibiting this process may have therapeutic effects in vivo. This 41 
study investigates the inhibitory effects of various bovine whey products on the 42 
association of Salm. typhimurium, E. coli O157:H7 and C. malonaticus (formerly 43 
Enterobacter sakazakii) to the human CaCo-2 cell line. Invasion of CaCo-2 cells by 44 
Salm. typhimurium and C. malonaticus was also examined. 45 
Methods and Results: Infection assays were performed by incubating pathogenic 46 
bacteria with CaCo-2 cells in the presence of untreated (UT) or enzyme-modified 47 
(EM) whey products. Associated microorganisms were directly quantified by plate 48 
counts. Invasion of CaCo-2 cells by Salm. typhimurium and C. malonaticus in the 49 
presence / absence of test materials was also quantified using gentamicin protection 50 
assays. At a concentration of 40mg ml-1, some UT whey products reduced association 51 
and invasion, but this effect was enhanced following hydrolysis with porcine 52 
pancreatic lipase.  53 
Conclusions: Both UT and EM Sweet whey protein concentrates (WPCs) were found 54 
to be particularly effective inhibitors of association and invasion. All EM whey 55 
products significantly (P<0.05) inhibited invasion of C. malonaticus into epithelial 56 
cells, causing a 2-log reduction in the quantity of these microorganisms internalised. 57 
Significance and Impact of the Study: The present study suggests that whey 58 
products can inhibit association to and invasion of CaCo-2 cells by selected 59 
microorganisms, and may be useful in the treatment and/or prevention of foodborne 60 
infections. 61 
 62 
 63 
 3 
Introduction            64 
                 Food consumed by humans is rarely sterile. Microorganisms present in 65 
food can lead to spoilage and/ or foodborne illness, with the latter causing millions of 66 
cases of infection and in some cases even death every year (Meng and Doyle, 1998). 67 
Salmonella typhimurium and Escherichia coli O157:H7 (enterohaemorrhagic E. coli, 68 
EHEC) have been recognised as pathogens for many years, but it is only in the last 30 69 
years that these bacteria have been considered to be predominantly foodborne (Meng 70 
and Doyle, 1998). Salmonellosis is a zoonotic infection, with infected animals being a 71 
major source of illness (Bezirtzoglou et al., 2000), and infection in humans is often 72 
due to consumption of undercooked poultry, eggs or egg-containing foods (Rodrigue 73 
et al., 1990). Salm. typhimurium is considered to be one of the most common causes 74 
of salmonellosis worldwide (WHO, 2005). E. coli is an inhabitant of the gut (both 75 
humans and animals), but some strains are pathogenic (Bezirtzoglou et al., 2000). E. 76 
coli O157:H7 is a clinically important food pathogen which can cause haemorrhagic 77 
colitis and haemolytic uremic syndrome (HUS) (Gu et al., 2008). EHEC has an 78 
extremely low infectious dose, and it is estimated that as few as 100 cells is adequate 79 
to cause infection (Kaper et al., 2004). Enterobacter sakazakii was listed as a new 80 
species in 1980, but a taxonomic reclassification of this microorganism has been 81 
proposed, as E. sakazakii has been found to consist of five species within a new genus 82 
now referred to as ‘Cronobacter’ (Iversen et al., 2007). Cronobacter malonaticus is 83 
one such subspecies. This bacterium is described as an emerging opportunistic 84 
pathogen, which can cause local necrotising enterocolitis, systemic bacteremia and 85 
meningitis (Kim and Loessner, 2008).  Cronobacter spp. has been isolated from milk 86 
powder, cheese, sausage meat, vegetables, bread, herbs and spices (Mullane et al., 87 
2007, Gurtler et al., 2005 and Kandhai et al., 2004), but powdered infant formula 88 
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(PIF) is considered to be a major vehicle of transmission, with neonates being most at 89 
risk of infection (Kim and Loessner, 2008).                  90 
                 Once ingested, microorganisms present in contaminated foods can adhere 91 
to the host’s cell surfaces. Adhesion of a microbe to a cell surface is considered to be 92 
the first step of pathogenesis (Finlay and Falkow, 1997). Lectins on the surface of 93 
bacteria adhere to specific receptors on epithelial cells of the intestinal tract 94 
(Nakajima et al., 2005). Some pathogenic microorganisms are capable of entering and 95 
surviving within epithelial cells following initial adherence, a process known as 96 
invasion (Finlay and Falkow, 1997). Cultured eukaryotic cell lines are a common 97 
method employed in the study of bacterial adherence and invasion as they provide 98 
researchers with reproducible and less complicated infection models (Tang et al., 99 
1993). One of the most extensively used is the CaCo-2 cell line, which was isolated 100 
from human colon carcinoma (Fogh et al., 1977). These cells, under standard culture 101 
conditions, differentiate to produce monolayers expressing characteristics of mature 102 
enterocytes (Pinto et al., 1983). 103 
                 Blocking the initial adherence of foodborne pathogens to intestinal 104 
epithelial cells may be a suitable approach to preventing occurrence of infections 105 
(Nakajima et al., 2005). Food components capable of inhibiting initial adherence are 106 
promising agents of intervention. Several carbohydrate components of food have 107 
exhibited a positive effect against intestinal infection (Nakajima et al., 2005), such as 108 
sialylated oligosaccharides from bovine or human milks (Sugitu-Konishi et al., 2002). 109 
Recently, whey and dairy products have been shown to reduce the adherence of the 110 
dental-caries causing bacterium Streptococcus mutans to hydroxylapatite, an analogue 111 
of tooth enamel (Halpin et al., 2008). Whey was once considered to be a waste-112 
product of the cheese-making process, but in recent years has had its status upgraded 113 
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to co-product and is described as a ‘functional food’ (Marshall, 2004). Many studies 114 
have shown enzymatic hydrolysis of whey proteins produces a plethora of peptides, 115 
exhibiting a wide array of bioactive properties (Meisel, 1998). 116 
                 The objective of this study was to examine the influence of a variety of 117 
whey products on the interaction of Salm. typhimurium, E. coli O157:H7 and 118 
Cronobacter malonaticus with CaCo-2 cells. The effect of pre-treating the whey 119 
products with PPL on any such influence was also examined.  120 
Materials and Methods 121 
Source and Analysis of Dairy Powders 122 
Sweet whey protein concentrate (WPC, 80% protein), acid WPC 80 (AWPC80), 123 
sweet WPC 35 (SWPC35), whey protein isolate (WPI), whey powder (WP) and 124 
demineralised whey (DW) powders were supplied by Carbery Milk Products 125 
(Ballineen, Cork, Ireland). Albumin from chicken egg white (grade V) was supplied 126 
by Sigma (Poole, Dorset, UK). 127 
Compositional analysis was performed on each whey product using standard methods. 128 
Ash content was determined according to Malkomesius & Nehring (1951). Fat 129 
content was determined according to the method of Röse-Gottlieb (International Dairy 130 
Federation (IDF) 1987), protein content was determined by the Kjeldahl method (IDF, 131 
1993) and the moisture content was determined by oven drying (IDF, 1993). 132 
Hydrolysis conditions 133 
Crude porcine pancreatic lipase (PPL, Sigma, Poole, Dorset, England)) containing 134 
100-400 units/ mg protein was used throughout the study. Hydrolysates were prepared 135 
in a Fermac 200 fermentor (Electrolab Ltd, Tewkesbury, UK) as follows: a c. 2% 136 
(w/v) solution of substrate was prepared by dissolving 20g of whey product in 900ml 137 
of sterile distilled water and heating to 37˚ C with stirring for 30mins. Lipase solution 138 
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(1g of PPL in 100ml of sterile H20) was added to the substrate solution to give a final 139 
incubation volume of 1 L. The hydrolysates were then incubated for 2 h at 37˚C with 140 
stirring. Following this, hydrolysates were heated at 60˚C for 10 min in order to 141 
denature the enzyme(s). Each hydrolysate was placed on ice and allowed to cool to 142 
below 10˚C (approx. 45 min), before being frozen using liquid nitrogen and 143 
subsequently lyophilised (Moduloyo, Edwards High Vacuum, Manor Royal, Crawley, 144 
Sussex, UK).  145 
Bacteria and Growth Conditions 146 
Salm. typhimurium (ATCC 14028) and E. coli O157:H7 (ATCC 43888) were 147 
obtained from the American Type Culture Collection (Rockville, MD, USA), and C. 148 
malonaticus (DSM 18702) was obtained from the German Collection of 149 
Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). Primary 150 
cultures were grown overnight in 10ml of Luria-Bertani (LB) broth (Sigma, Poole, 151 
Dorset, UK) at 37°C. A 1% inoculum was prepared by adding 400µl of overnight 152 
culture to 39.6ml of fresh pre-warmed LB broth before re-incubating at 37°C. Salm. 153 
typhimurium and E. coli O157:H7 were grown to mid-log phase. C. malonaticus was 154 
grown to late-log phase, as it has been recently reported that adherence of E. sakazakii 155 
is at it’s maximum at this stage of growth, after at least 4 h of culturing (Mange et al., 156 
2006). Bacteria were then collected by centrifugation at 3220 × g (Eppendorf 5810R, 157 
Cambridge, UK) for 10 min and were resuspended in supplement-free Dubleco’s 158 
Modified Eagle’s Medium (DMEM, Gibco), so that the final concentration of bacteria 159 
was approx. 108 cells per millilitre. 160 
CaCo-2 Cell Culture 161 
CaCo-2 cells were obtained from the European Collection of Cell Cultures (ECACC, 162 
Wiltshire, UK). At late confluency these cells express both structural and functional 163 
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characteristics of enterocytes present in the small intestine (Hendricks et al., 1996). 164 
Cells were routinely cultured in DMEM supplemented with 10% heat-inactivated 165 
foetal bovine serum (FBS), 1% non-essential amino acids 100X, 1% 166 
penicillin/streptomycin solution and 1% fungizone containing 250µg/ml amphotericin 167 
B. All supplements were supplied by Gibco. The cells were initially grown in T75cm2 168 
flasks (Sarstedt, Nümbrecht, Germany) and upon confluency (approx. 1.5 ×106 169 
cells/ml, 7-10 days) were passaged using 0.25% trypsin (Gibco). For infection assays, 170 
monolayers were cultured in 24-well tissue culture plates (Sarstedt, Nümbrecht, 171 
Germany). CaCo-2 cells were seeded at a density of 5 × 105 cells/well, and growth 172 
medium was changed every other day. These cells are known to be fully differentiated 173 
after being cultured for 19 days (Koninkx, 1995). Maintenance of cells and 174 
subsequent experiments were carried out at 37°C in a 5% CO2-95% air atmosphere 175 
(Binder Apt Line C150, Tuttlingen, Germany), between passage number 37 and 55, 176 
with c. 106 CaCo-2 cells per well. 177 
Viabilty of Bacterial and Epithelial Cells 178 
The trypan blue (Sigma, Poole, Dorset, UK) dye exclusion test was used to determine 179 
if test materials affected viability of CaCo-2 cells. Test materials were prepared in 180 
supplement-free DMEM (SFM) and added to wells containing monolayers, followed 181 
by incubation for 1 hour at 37°C and 5% CO2. The monolayers were then washed 182 
twice with SFM, before being trypsinised and added to 0.4% trypan blue (1:1). An 183 
inverted light microscope (Ceti, Belgium) was used to examine cells to determine 184 
viability. Viable epithelial cells exclude trypan blue while dead cells allow entry, and 185 
appear blue when viewed under the microscope. The percentage viability was 186 
calculated as follows:  187 
100-(Number of dead cells/ Total Number of cells × 100)  188 
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Viability of bacteria was determined by direct contact studies, where each 189 
microorganism was incubated with test materials under typical assay conditions and 190 
subsequently enumerated by spread plates following appropriate dilution. As whey 191 
products are not sterile, selective agars were used to quantify the number of 192 
pathogenic bacteria (i.e. to eliminate any ‘background count’ due to microorganisms 193 
such as lactobacilli). Brilliant green, McConkey and Chromogenic Enterobacter 194 
sakazakii agars (DFI formulation) (Oxoid, Hampshire, UK) were used to selectively 195 
cultivate Salm. typhimurium, E. coli O157:H7 and Cronobacter malonaticus, 196 
respectively. 197 
Infection Assays 198 
Prior to infection assays, CaCo-2 cells were washed twice in sterile phosphate-199 
buffered saline (PBS, Sigma, Poole, Dorset, UK) to remove traces of antibiotic, and 200 
equilibrated in SFM at 37°C and 5% CO2 for at least 2 h. (i) Association and (ii) 201 
invasion of pathogenic bacteria were examined as follows: 202 
(i) Quantification of Association 203 
Aliquots (500µl) of test material dispersed in SFM (80mg ml-1) or 500µl of SFM (to 204 
act as a negative control) were added to each well, followed by 500µl of pathogens 205 
suspended in SFM (c. 108 CFU ml-1). The final concentration of test material was 206 
40mg ml-1. Monolayers were challenged in triplicate wells at a multiplicity of 207 
infection (MOI) of 100:1 (bacteria: epithelial cells). The plates were then incubated at 208 
37°C and 5% CO2 for 1 h.  Following this, the monolayers were washed twice with 209 
SFM in order to remove non-adhered and loosely adhered bacteria. Cells were 210 
overlayed with SFM and further incubated for 30min at 37˚C and 5% CO2. 211 
Monolayers containing associated (i.e. adhered and invaded) bacteria were lysed (in 212 
order to liberate the microorganisms) with a 1ml volume of 1% triton-X-100 (Sigma, 213 
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Poole, Dorset, UK) prepared in sterile PBS, for 5min at room temperature. This 1ml 214 
volume was serially diluted in PBS and spread plates were prepared using selective 215 
agars. 216 
(ii) Quantification of Invasion 217 
CaCo-2 cells were treated as previously described for the association assay. After the 218 
non-adherent bacteria had been removed by washing with SFM, CaCo-2 cells were 219 
treated with gentamicin (Gibco) in order to quantify invasion. Gentamicin (an 220 
antibiotic) does not diffuse into CaCo-2 cells, so any externally adhered bacteria are 221 
rapidly killed but the viability of any invaded bacteria is not affected. Briefly, 222 
gentamicin was prepared to a concentration of 50µg ml-1 in SFM and added to wells, 223 
and monolayers were again incubated for 30min at 37°C and 5% CO2, before being 224 
washed twice with PBS to remove excess antibiotic. Epithelial cells were then lysed 225 
in order to liberate invaded pathogens and spread plates prepared as described earlier. 226 
The quantity of associated/ invaded pathogenic bacteria in SFM was assigned to 227 
100%. Thus, percentage association/ invasion was expressed relative to the control (in 228 
the absence of test material) as follows: (Number of bacteria associated or invaded in 229 
presence of test material/ Number of bacteria associated or invaded in presence of 230 
DMEM alone) × 100 231 
Mechanism of Inhibition Assays 232 
In an attempt to determine if test material interacted with either epithelial cells or 233 
bacteria or both, CaCo-2 cells and bacteria were separately pre-incubated with test 234 
material for 1 h at 37˚C and 5% CO2 prior to performing infection assays as described 235 
earlier. 236 
Statistical Analysis 237 
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Experiments were carried out using three bacterial cultures (n=3) for each treatment. 238 
Results were expressed as the mean ± standard deviation (S.D.). Differences between 239 
inhibitory effects of each treatment were determined using the general linear models 240 
(GLM) function of SAS Version 9.1.3. Data were considered significantly different if 241 
P<0.05. 242 
Results 243 
The compositional analysis of each test material was determined, along with the pH 244 
value of each whey product in its untreated and enzyme-modified form (Table 1). Test 245 
materials were dispersed in DMEM at a concentration of 40mg ml-1 prior to 246 
measuring pH, and the pH values of DMEM alone and egg albumin were 7.1 and 247 
7.08, respectively. Enzyme-treatment was found to lower the pH of all whey products. 248 
Growth curves for each microorganism are shown in Figure 1. Test materials were not 249 
found to reduce viability of either CaCo-2 cells or bacteria at a concentration of 40mg 250 
ml-1 (data not shown). 251 
(i) Salm. typhimurium 252 
In the absence of test material, Salm. typhimurium associated to and invaded CaCo-2 253 
cells at levels of 107 and 106 CFU ml-1/well, respectively, and this is represented by 254 
the DMEM bars in Figure 2(a) and (b) as 100% association/ invasion. Of the untreated 255 
materials tested, all but AWPC80, DW and the protein control, egg albumin, 256 
significantly reduced association of Salm. typhimurium to CaCo-2 cells (P<0.05). UT 257 
SWPC80 was significantly more effective than the other materials, reducing 258 
association by c. 60% (P<0.05). With one exception (WP), pre-treatment of these 259 
whey products with PPL increased their ability to subsequently reduce Salm. 260 
typhimurium association, although the reduction in association brought about by this 261 
treatment was not always significant (Figure 2(a)). 262 
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In the invasion assays, of the untreated products examined, only SWPC80 and 263 
SWPC35 and to a lesser extent WPI reduced invasion significantly (P<0.05). UT 264 
AWPC80 appeared to enhance invasion of Salm. typhimurium into CaCo-2 cells 265 
(Figure 2(b)). All EM whey products were significant inhibitors of invasion (P<0.05), 266 
with EM-SWPC35 showing the greatest reduction (c. 75%). EM-SWPC80, EM-267 
AWPC80, EM-WPI and EM-WP exhibited similar levels of activity, reducing 268 
invasion of this microorganism into CaCo-2 cells by 40-50%. EM-DW was the least 269 
effective of the hydrolysates, but still reduced invasion by 26%. 270 
(ii) E. coli O157:H7 271 
Under the experimental conditions described here, approximately 106 CFU ml-1/well 272 
of E. coli O157:H7 cells associated to CaCo-2 monolayers in the absence of test 273 
material (representing 100% association, Figure 3). The presence of all UT materials 274 
with the exception of DW significantly reduced association of E. coli O157:H7 with 275 
CaCo-2 cells, as observed previously (P<0.05). UT SWPC80 was again the most 276 
potent in this regard, reducing association by c. 60%. Interestingly, UT AWPC80 277 
which did not reduce association of Salm. typhimurium inhibited association of E. coli 278 
O157:H7 with CaCo-2 cells.  279 
Pre-treatment with PPL did not significantly increase the ability of the materials to 280 
reduce association (P>0.05). An exception in this regard was EM-AWPC80, which 281 
showed the greatest reduction in association (>60% inhibition) of the materials 282 
studied. Also it should be noted that egg albumin, the protein control, was an effective 283 
inhibitor of association of E. coli O157:H7 with CaCo-2 cells, being only significantly 284 
less effective than EM-AWPC80 (P<0.05).  285 
Invasion of this microorganism in the presence of the test materials was not examined 286 
here, as it has been reported that E. coli O157:H7 does not invade into all cell lines, 287 
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but this does not necessarily mean that this bacterium is tissue culture non-invasive 288 
(Oelschlaeger et al., 1994). 289 
(iii) C. malonaticus 290 
This microorganism showed similar levels of association with and invasion of CaCo-2 291 
cells as those observed for Salm. typhimurium (107 and 106, respectively). Again these 292 
values represent 100% association or invasion (Figure 4(a) and (b), respectively). UT 293 
AWPC80 increased association of C. malonaticus to CaCo-2 cells by approx. 20% 294 
(Figure 4(a)). No significant differences were noted between the potency of UT 295 
SWPC80, UT SWPC35, UT WPI and UT WP, but each of these whey products were 296 
found to be more effective than DMEM alone (P<0.05), causing a 35-40% reduction 297 
in association. For the enzyme-modified products, EM-SWPC80, EM-SWPC35 and 298 
EM-WPI were the most effective test materials, reducing association by 35-45%. EM-299 
AWPC80, EM-WP and EM-DW had no significant effect on association of this 300 
bacterium to monolayers (P>0.05). Egg albumin was found to significantly increase 301 
association of C. malonaticus to the CaCo-2 cell line, and showed least inhibitory 302 
activity when compared to untreated and enzyme-modified whey products (P<0.05).  303 
For the invasion assays, UT AWPC80 appeared to increase invasion of C. 304 
malonaticus into epithelial cells (Figure 4(b)). Of the untreated whey products, the 305 
most effective inhibitors of invasion were UT WP and UT WPI, which showed 306 
greater reductions than UT SWPC80 and UT SWPC35 (P <0.05). UT DW had no 307 
significant (P>0.05) effect on invasion. However, all enzyme-modified whey products 308 
greatly reduced invasion of C. malonaticus into CaCo-2 cells, causing a 2-log 309 
reduction when compared to DMEM alone (106→ 104 CFU ml-1/well). EM-WP and 310 
EM-DW were slightly less effective than other test materials, nevertheless causing a 311 
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reduction of 92 and 88%, respectively (Figure 4(b)). Egg albumin, the protein control, 312 
neither increased nor reduced invasion of this microorganism into CaCo-2 cells. 313 
(iv) Mechanism of Action 314 
EM-SWPC80 was the test material chosen for mechanistic experiments, as this whey 315 
product was found to be a very effective inhibitor of association of Salm. 316 
typhimurium, E. coli O157:H7 and C. malonaticus to CaCo-2 cells. A reduction in 317 
association was observed for these microorganisms when the bacteria and test 318 
material were added simultaneously to the test wells. However, with the exception of 319 
C. malonaticus, pre-treatment of the microorganisms with EM-SWPC80 generally did 320 
not reduce association, nor did pre-treatment of the epithelial cells (Table 2).  321 
Discussion 322 
                 Adherence to the host’s cell surface is a vital step in pathogenesis of 323 
gastrointestinal tract (GIT) infection as it prevents microorganisms from being swept 324 
away by bulk fluid movement. Once a microbe adheres, it can readily access 325 
nutrients, while being able to deliver toxins into host tissues before eventually 326 
penetrating these tissues (Acord et al., 2005). The aim of anti-adhesion therapy is 327 
essentially to reduce contact between pathogens and host tissues, by preventing or 328 
reversing adherence. Currently, some of the most efficient known inhibitors of 329 
adhesion are found in foodstuffs (Ofek et al., 2003). In the present study, the effect of 330 
native and enzyme-modified whey products on association of Salm. typhimurium, E. 331 
coli O157:H7 and C. malonaticus to human CaCo-2 cells was examined, along with 332 
their effects on the invasion of such cells by Salm. typhimurium and C. malonaticus. 333 
Whey is currently described as a ‘functional food’, as it possesses a wide array of 334 
health benefits, and undenatured whey can provide high concentrations of intact 335 
proteins such as lactoferrin and immunoglobulins (Marshall, 2004). The results 336 
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described here indicate that, with the exception of AWPC80 and DW, most UT whey 337 
products were effective inhibitors of both association and invasion. However, the 338 
activity of these whey products was enhanced following hydrolysis with PPL, with 339 
EM-SWPC80 and EM-SWPC35 causing particularly high reductions.                  340 
                 Each whey product has varying levels of fat, protein, moisture, ash and 341 
lactose (Table 1). Sweet and acid WPCs have similar levels of protein and fat etc., yet 342 
the sweet WPCs were found to have greater anti-adhesion/ invasion activity. WPI has 343 
almost no fat, yet still exhibited significant anti-adhesive and anti-invasion activity. 344 
WP and DW contain less protein and fat than the WPCs and WPI, but have a high 345 
content of lactose. In a report by Coppa et al. (2006), lactose from human milk 346 
(concentration not given) was not found to inhibit association of E.coli (serotype 347 
O119) or Salm. fyris to CaCo-2 cells. In the present study, inhibition of association 348 
and invasion of pathogenic bacteria by the whey products was generally more potent 349 
than that of egg albumin, suggesting the activity is not due to a non-specific protein 350 
effect. Whey proteins are recognised as having superior biological activity to other 351 
proteins, and the activity of peptides encrypted within such proteins usually remains 352 
latent until they are subjected to proteolytic action of enzymes (Sinha et al., 2007). 353 
The crude PPL used in the present study is known to contain both proteases and 354 
lipases, and it may be that enzyme pre-treatment of the whey products listed here 355 
releases species such as specific peptides or free fatty acids that are latent within the 356 
untreated material. The observation that potency of these materials was not 357 
diminished after enzyme-treatment may indicate that the active components could 358 
survive passage through the gut. This would be a favourable characteristic for using 359 
whey products to prevent/ treat infection of the GIT. 360 
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                One potential hypothesis as to why high levels of inhibition were observed 361 
for sweet WPCs may be because of the presence of glycomacropeptide (GMP). GMP, 362 
also referred to as the ‘casein macropeptide’ is present in sweet (rennet) whey as a 363 
result of the action of the chymosin enzyme on κ-casein during the cheese-making 364 
process (Marshall, 2004).  This peptide is known to inhibit bacterial and viral 365 
adhesion (Kawasaki et al., 1993, Simon, 1996), and is capable of binding to E. coli 366 
O157:H7 and Salmonella enteridis when in its sialylated form (Nakajima et al., 2005). 367 
In a study by Bruck et al. (2006), the effect of GMP on the association of 368 
enteropathogenic E. coli (EPEC) and Salm. typhimurium to CaCo-2 cells was 369 
examined, and they found that undigested GMP (0.25mg ml-1) reduced association of 370 
these bacteria. They also reported that enzyme digestion with pepsin and pancreatin 371 
increased the anti-adhesive activity of GMP. It was concluded that fragments 372 
produced by digestion with both pancreatin and pepsin digestion of GMP were most 373 
potent for Salm. typhimurium, but peptides liberated from digestion with pepsin alone 374 
significantly reduced association levels of EPEC  (P<0.05-0.001). However, isolated 375 
and purified GMP is an expensive resource. Our study has shown that native sweet 376 
WPC products, which are inexpensive and readily available, are effective inhibitors of 377 
bacterial association and invasion. Enzyme-modifying such material with PPL is also 378 
a relatively inexpensive and straightforward process, and enhances the anti-adhesive 379 
and anti-invasive activity of sweet WPCs. 380 
                In a study by de Araujo and Giugliano (2000), it was reported that whey 381 
produced from human milk (0.97mg ml-1) inhibited association of diffusely adherent 382 
E. coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells by 9% and 16%, 383 
respectively. In a subsequent study by the same researcher in 2001, the free secretory 384 
component (105μg ml-1) and lactoferrin (157μg ml-1) isolated from human milk, 385 
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inhibited adherence of EPEC to HeLa cells by 32% and 4.5%, respectively. The 386 
immunoglobulin fraction was also found to reduce adherence of these bacteria to 387 
HeLa cells (de Araujo and Giugliano, 2001). da Motta Willer and co-workers (2004) 388 
found that whey from human milk (2.8mg ml-1) could reduce adhesion of Shigella 389 
strains to HeLa cells by at least 40%, and invasion was reduced by more than 50%. It 390 
was also reported that human lactoferrin (0.3 mg ml-1) reduced invasion by 50- 65% 391 
(da Motta Willer et al., 2004). It is possible that the equivalent components of bovine 392 
milk/ whey could inhibit association and/ or invasion of pathogens to epithelial cells. 393 
                 Non-protein components of whey include oligosaccharides and lipids, 394 
including sphingolipids (Shoaf et al., 2006). Certain oligasaccharides are similar in 395 
structure to receptor sites (recognised and adhered to by pathogens) coating epithelial 396 
cells of the intestine. Thus, oligosaccharides possibly act as molecular receptor 397 
decoys, competitively inhibiting microbial adherence. Conversely, instead of 398 
pathogens adhering to the host cell surfaces, they would bind to the decoy 399 
oligosaccharides and be displaced from the GIT (Shoaf et al., 2006). Oligosaccharides 400 
present in the whey products used in our study may be contributing to the anti-401 
adhesive activities of these materials. Another characteristic of the test materials used 402 
in this study which should be taken into consideration are the pH values of individual 403 
products when in solution. Treatment with PPL reduced the pH of all test materials, 404 
due to liberation of free fatty acids and amino acids during-hydrolysis. It is possible 405 
that the fimbrial protein structures of pathogenic microorganisms are influenced by 406 
different pH values (close to their pI values), reducing the capability of bacteria to 407 
adhere to epithelial cells (Lehto and Salminen, 1997). This may be a contributing 408 
factor in the reduction in association of Salm. typhimurium, E. coli O157:H7 and C. 409 
malonaticus to CaCo-2 cells in the presence of whey products, which was observed in 410 
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the results reported here. Preliminary results have shown that inhibition of association 411 
is greatest when EM-SWPC80 and bacteria are added simultaneously to monolayers 412 
(Table 2). However, whether this inhibitory effect is due to proteins, fats, pH, 413 
oligosaccharides, immunoglobulins, lactobacilli etc. present in whey or a combination 414 
of these is not yet clear and the exact mechanism of action of these products to 415 
prevent association / invasion of pathogenic bacteria to epithelial cells remains to be 416 
elucidated, but it is not unreasonable to speculate that the inhibitory effect is because 417 
of the presence of GMP. 418 
 Although CaCo-2 cells are regarded as one of the best in vitro models of 419 
mature enterocytes, such cell systems have their limitations (Giannasca et al., 1996), 420 
such as the absence of host factors (e.g. mucus barriers, immune factors). In addition, 421 
cell culture models do not possess other host cells that would normally be present in 422 
vivo e.g. inflammatory cells (Finlay and Falkow, 1997). Nevertheless, the results of 423 
the present study are positive from a cell culture perspective. 424 
Individuals most at risk from foodborne infection include newborns, elderly 425 
people and those who are immunocompromised (Sprong et al., 1999). Treatments for 426 
infection due to foodborne pathogens such as those caused by E. coli O157:H7 is for 427 
the most part supportive, as practitioners are reluctant to prescribe antibiotics due to 428 
the risk of complications, such as acute renal failure in patients with HUS (Meng and 429 
Doyle, 1998). Also, the emergence of multi-drug resistant strains of Salm. 430 
typhimurium has led to a limited number of treatment options, in particular for 431 
invasive infections (Meng and Doyle, 1998). Thus, the use of antibiotics to treat 432 
foodborne illness is no longer desirable due to complications which are likely to 433 
occur. These include incidences of drug resistant strains and the potential for chronic 434 
toxicity (Lin et al., 2007). As a result, alternative approaches to preventing infections 435 
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of the GIT have been sought. Whey products, in either their untreated or enzyme-436 
modified form may be suitable alternatives to treat or preferably prevent illness due to 437 
foodborne pathogens. 438 
Conclusion 439 
Both untreated and enzyme-modified whey products are effective inhibitors of 440 
association of Salm. typhimurium, E. coli O157:H7 and C. malonaticus to CaCo-2 441 
cells and may be suitable for in vivo use to prevent and/ or treat GIT infection due to 442 
foodborne pathogens.  443 
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Legends for figures: 585 
Figure 1:  Growth curves of Salm. typhimurium (●), E. coli O157:H7 (■) and C. 586 
malonaticus (▲) in LB broth. 587 
Figure 2: The Effect of DMEM (■), Untreated Whey Products (□), Enzyme-588 
Modified Whey Products (■) and Egg Albumin* on the (a) Association and (b) 589 
Invasion of Salm. typhimurium to/ into CaCo-2 cells. (Data= mean ± S.D., n=3) 590 
* Egg Albumin is included in this figure for comparison only 591 
Figure 3: The Effect of DMEM (■), Untreated Whey Products (□), Enzyme-592 
Modified Whey Products (■) and Egg Albumin* on the Association of E. coli 593 
O157:H7  to CaCo-2 cells. (Data= mean ± S.D., n=3) 594 
* Egg Albumin is included in this figure for comparison only 595 
Figure 4: The Effect of DMEM (■), Untreated Whey Products (□), Enzyme-596 
Modified Whey Products (■) and Egg Albumin* on the (a) Association and (b) 597 
Invasion of C. malonaticus to/ into CaCo-2 cells. (Data= mean ± S.D., n=3) 598 
* Egg Albumin is included in this figure for comparison only 599 
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Notes: All test materials were used at a concentration of 40mg mL-1. Means with the 631 
same letter are not significantly different (at the 5% significance level). 632 
Abbreviations: DMEM= Dubleco’s Modified Eagle’s Medium, SWPC80= Sweet 633 
Whey Protein Concentrate 80, AWPC80= Acid WPC80, SWPC35= Sweet Whey 634 
Protein Concentrate 35, WPI= Whey Protein Isolate, WP= Whey Powder, DW= 635 
Demineralised Whey, Egg Alb= Egg Albumin.  636 
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Notes: All test materials were used at a concentration of 40mg mL-1. Means with the 641 
same letter are not significantly different (at the 5% significance level). 642 
Abbreviations: DMEM= Dubleco’s Modified Eagle’s Medium, SWPC80= Sweet 643 
Whey Protein Concentrate 80, AWPC80= Acid WPC80, SWPC35= Sweet Whey 644 
Protein Concentrate 35, WPI= Whey Protein Isolate, WP= Whey Powder, DW= 645 
Demineralised Whey, Egg Alb= Egg Albumin.  646 
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Notes: All test materials were used at a concentration of 40mg mL-1. Means with the 665 
same letter are not significantly different (at the 5% significance level). 666 
Abbreviations: DMEM= Dubleco’s Modified Eagle’s Medium, SWPC80= Sweet 667 
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Table 1: Compositional analysis of whey products used in this study (%) and pH 672 
values of test materials before and after treatment with porcine pancreatic lipase. 673 
 SWPC80 AWPC80 SWPC35 WPI WP DW 
Protein 75.5 78.2 34.3 86.6 12.5 13 
Fat 8 7.7 3.4 0.1 1 1.8 
Moisture 7.5 6.3 5.4 5.8 3.1 3.5 
Ash 3 5.9 6.2 2.6 9.5 0.8 
Lactose 6 1.9 50.7 4.9 73.9 80.9 
pH UT 7.16 7.26 7.22 7.11 7.17 7.22 
pH EM 6.48 6.56 6.58 6.56 7.01 6.97 
 674 
Abbreviations: SWPC80= Sweet Whey Protein Concentrate 80, AWPC80= Acid 675 
WPC80, SWPC35= Sweet Whey Protein Concentrate 35, WPI= Whey Protein Isolate, 676 
WP= Whey Powder, DW= Demineralised Whey. 677 
UT= untreated, EM= enzyme-modified with porcine pancreatic lipase.  678 
 679 
Table 2: Levels of Association (%) of S. typhimurium, E. coli O157:H7 and C. 680 
malonaticus to CaCo-2 Cells in the presence of EM- SWPC80 (40mg ml-1) under 681 
Varying Assay Conditions. 682 
 S. typhimurium E. coli O157:H7 C. malonaticus 
(a) EM-SWPC80 and 
bacteria added 
simultaneously 
(i) 33.3 
(ii) 44.1 
(iii) 61.8 
(i) 50.8 
(ii) 67.5 
(iii) 73.7 
(i) 62.2 
(ii) 43.6 
(b) Bacteria pre-
treated with EM-
SWPC80 
(i) No reduction 
(ii) No reduction 
(iii) No reduction 
(i) 93.2 
(ii) No reduction 
(iii) 71.9 
(i) 58.1 
(ii) 39.2 
(c)CaCo-2 cells pre-
treated with EM-
SWPC80 
(i) No reduction 
(ii) No reduction 
(iii) No reduction 
(i) 88.5 
(ii) No reduction 
(iii) No reduction 
(i) No reduction 
(ii) No reduction 
Abbreviations: EM-SWPC80= Enzyme-modified Sweet Whey Protein Concentrate 80 683 
Association of bacteria in DMEM alone was assigned to 100% 684 
